First Horizon Corporation’s Amicus Therapeutics FOLD Stock Holding History

First Horizon Corporation’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,345	Closed	-$62.8K	–	1554
2026 Q1	$62.8K	Sell	4,345 -441	-9%	-$6.32K	﹤0.01%	581
2025 Q4	$68.2K	Buy	4,786 +2,648	+124%	+$26K	﹤0.01%	596
2025 Q3	$16.8K	Buy	+2,138	New	+$15.2K	﹤0.01%	918
2021 Q2	$2K	Hold	286	–	–	﹤0.01%	945
2021 Q1	$2K	Buy	286 +5	+2%	+$77	﹤0.01%	920
2020 Q4	$6K	Buy	+281	New	+$5.75K	﹤0.01%	763

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

First Horizon Corporation's FOLD Position: Q2 2026 in Review

First Horizon Corporation sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 4,345 shares — an estimated $62.8K sold.

First Horizon Corporation first reported a position in FOLD in Q4 2020 and held it in 6 quarters. The position peaked at $68.2K in Q4 2025. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

First Horizon Corporation reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
First Horizon Corporation sold 4,345 Amicus Therapeutics shares in Q2 2026, an estimated $62.8K.
First Horizon Corporation first reported a position in Amicus Therapeutics in Q4 2020 and held it in 6 quarters.
First Horizon Corporation's Amicus Therapeutics position peaked at $68.2K in Q4 2025.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.